Boehringer Ingelheim Pharmaceuticals | Jobs at Boehringer Ingelheim Pharmaceuticals
Boehringer Ingelheim Pharmaceuticals Inc. will pay $95 million to settle government claims it improperly promoted four drugs, the U.S. Justice Department said.
The accord ends a federal False Claims Act lawsuit in Maryland filed by Robert Heiden, a former company sales representative, the government said today in a statement. Heiden will get $17 million for his role as whistle-blower.
Boehringer Ingelheim Pharmaceuticals Inc. will pay $95 million to settle government claims it improperly promoted four drugs, the U.S. Justice Department said.
The accord ends a federal False Claims Act lawsuit in Maryland filed by Robert Heiden, a former company sales representative, the government said today in a statement. Heiden will get $17 million for his role as whistle-blower.
